Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Carlos Urey, Bodil Andersson, Daniel Ansari, Agata Sasor, Katarzyna Said-Hilmersson, Johan Nilsson & Roland Andersson. (2017) Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine. Scandinavian Journal of Gastroenterology 52:5, pages 595-600.
Read now
Read now
Articles from other publishers (19)
Ashleigh Hull, William Hsieh, William Tieu, Dylan Bartholomeusz, Yanrui Li & Eva Bezak. (2023) In vitro characterisation of [177Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancer. EJNMMI Radiopharmacy and Chemistry 8:1.
Crossref
Crossref
Ashleigh Hull, Yanrui Li, Dylan Bartholomeusz, William Hsieh, William Tieu, Tara L. Pukala, Alexander H. Staudacher & Eva Bezak. (2022) Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma. Cells 11:19, pages 2983.
Crossref
Crossref
Luana Barbosa Corrêa, Suyene Rocha Pinto, Luciana Magalhães Rebelo Alencar, Sotiris Missailidis, Elaine Cruz Rosas, Maria das Graças Muller de Oliveira Henriques & Ralph Santos-Oliveira. (2022) Nanoparticle conjugated with aptamer anti-MUC1/Y for inflammatory arthritis. Colloids and Surfaces B: Biointerfaces 211, pages 112280.
Crossref
Crossref
Shivanand Pudakalakatti, José S. Enriquez, Caitlin McCowan, Saleh Ramezani, Jennifer S. Davis, Niki M. Zacharias, Dontrey Bourgeois, Pamela E. Constantinou, Daniel A. Harrington, Daniel Carson, Mary C. Farach‐Carson & Pratip K. Bhattacharya. (2021)
Hyperpolarized
MRI
with silicon micro and nanoparticles: Principles and applications
. WIREs Nanomedicine and Nanobiotechnology 13:6.
Crossref
Crossref
Elizabeth Pham, Matthias Friedrich, Famke Aeffner, Michael Lutteropp, Natalie F. Mariano, Petra Deegen, Christoph Dahlhoff, Franziska Vogel, Claudia Bluemel, John M. Harrold, Christian Brandl, Natalia Grinberg, Benno Rattel, Angela Coxon & Julie M. Bailis. (2021) Preclinical Assessment of a MUC12-Targeted BiTE (Bispecific T-cell Engager) Molecule. Molecular Cancer Therapeutics 20:10, pages 1977-1987.
Crossref
Crossref
Rafael Martinez-Carrasco, Pablo Argüeso & M. Elizabeth Fini. (2021) Membrane-associated mucins of the human ocular surface in health and disease. The Ocular Surface 21, pages 313-330.
Crossref
Crossref
Ashleigh Hull, Yanrui Li, Dylan Bartholomeusz, William Hsieh, Samantha Escarbe, Andrew Ruszkiewicz & Eva Bezak. (2020) The Expression Profile and Textural Characteristics of C595-Reactive MUC1 in Pancreatic Ductal Adenocarcinoma for Targeted Radionuclide Therapy. Cancers 13:1, pages 61.
Crossref
Crossref
Bina Kashyap & Arja M. Kullaa. (2020) Regulation of mucin 1 expression and its relationship with oral diseases. Archives of Oral Biology 117, pages 104791.
Crossref
Crossref
B.W. Huisman, J. Burggraaf, A.L. Vahrmeijer, J.W. Schoones, R.A. Rissmann, C.F.M. Sier & M.I.E. van Poelgeest. (2020) Potential targets for tumor-specific imaging of vulvar squamous cell carcinoma: A systematic review of candidate biomarkers. Gynecologic Oncology 156:3, pages 734-743.
Crossref
Crossref
M. Elizabeth Fini, Shinwu Jeong, Haiyan Gong, Rafael Martinez-Carrasco, Nora M.V. Laver, Minako Hijikata, Naoto Keicho & Pablo Argüeso. (2020) Membrane-associated mucins of the ocular surface: New genes, new protein functions and new biological roles in human and mouse. Progress in Retinal and Eye Research 75, pages 100777.
Crossref
Crossref
Silvia Catuogno, Carla Esposito, Paola Ungaro & Vittorio de Franciscis. (2018) Nucleic Acid Aptamers Targeting Epigenetic Regulators: An Innovative Therapeutic Option. Pharmaceuticals 11:3, pages 79.
Crossref
Crossref
Pamela A. Trail, Gene M. Dubowchik & Timothy B. Lowinger. (2018) Antibody drug conjugates for treatment of breast cancer: Novel targets and diverse approaches in ADC design. Pharmacology & Therapeutics 181, pages 126-142.
Crossref
Crossref
Pengpeng Xia, Agnes Hakyung Choi, Zengping Deng, Yuqian Yang, Jing Zhao, Yiting Wang, Philip R. Hardwidge & Guoqiang Zhu. (2016) Cell membrane-anchored MUC4 promotes tumorigenicity in epithelial carcinomas. Oncotarget 8:8, pages 14147-14157.
Crossref
Crossref
Micaela Morgado, Margie N. Sutton, Mary Simmons, Curtis R. Warren, Zhen Lu, Pamela E. Constantinou, Jinsong Liu, Lewis LW. Francis, R. Steven Conlan, Robert C. BastJr.Jr. & Daniel D. Carson. (2016) Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκB. Oncotarget 7:12, pages 14871-14884.
Crossref
Crossref
Agnieszka Gornowicz, Anna Bielawska, Robert Czarnomysy, Halina Gabryel-Porowska, Anna Muszyńska & Krzysztof Bielawski. (2015) The combined treatment with novel platinum(II) complex and anti-MUC1 increases apoptotic response in MDA-MB-231 breast cancer cells. Molecular and Cellular Biochemistry 408:1-2, pages 103-113.
Crossref
Crossref
Tania Patino, Ujjwal Mahajan, Raghavendra Palankar, Nikolay Medvedev, Jakob Walowski, Markus Münzenberg, Julia Mayerle & Mihaela Delcea. (2015) Multifunctional gold nanorods for selective plasmonic photothermal therapy in pancreatic cancer cells using ultra-short pulse near-infrared laser irradiation. Nanoscale 7:12, pages 5328-5337.
Crossref
Crossref
Isabella Tavernaro, Sebastian Hartmann, Laura Sommer, Heike Hausmann, Christian Rohner, Martin Ruehl, Anja Hoffmann-Roeder & Sabine Schlecht. (2015) Synthesis of tumor-associated MUC1-glycopeptides and their multivalent presentation by functionalized gold colloids. Organic & Biomolecular Chemistry 13:1, pages 81-97.
Crossref
Crossref
Justin P Dassie & Paloma H Giangrande. (2013) Current progress on aptamer-targeted oligonucleotide therapeutics. Therapeutic Delivery 4:12, pages 1527-1546.
Crossref
Crossref
Furong Dai, Yi Zhang, Xin Zhu, Nianchun Shan & Yuxiang Chen. (2012) Anticancer role of MUC1 aptamer–miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation. Targeted Oncology 7:4, pages 217-225.
Crossref
Crossref